Celcuity (CELC) Liabilities and Shareholders Equity (2016 - 2026)
Celcuity (CELC) reported Liabilities and Shareholders Equity of $828.22 million for Q2 2026, up 351.1% from $183.59 million a year earlier.
Celcuity (CELC) Liabilities and Shareholders Equity (2016 - 2026) Analysis & Trends
At the end of FY2025, Celcuity posted Liabilities and Shareholders Equity of $466.56 million, up 90.3% from FY2024.
- Liabilities and Shareholders Equity has increased for five consecutive years, with a five-year compound annual growth rate of 104.8% (FY2020 to FY2025).
- By year, Liabilities and Shareholders Equity came in at $245.12 million in FY2024 (+28.2%), $191.22 million in FY2023 (+8.8%), $175.7 million in FY2022 (+104.5%) and $85.91 million in FY2021 (+563.0%).
- The Q2 2026 figure ranks as the highest quarterly Liabilities and Shareholders Equity in data going back to Q4 2016.
- Year over year, Liabilities and Shareholders Equity gained in six of the last seven quarters, with growth averaging 87.8%.
- The high point for year-over-year Liabilities and Shareholders Equity in five years was Q4 2021 (growth of 563.0%); the low point was Q2 2025 (a decline of 37.2%).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Celcuity | 3.89 Bn | 3.89 Bn | - | 828.22 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 828.22 Mn |
| Dec 31, 2025 | 466.56 Mn |
| Sep 30, 2025 | 476.00 Mn |
| Jun 30, 2025 | 183.59 Mn |
| Mar 31, 2025 | 218.13 Mn |
| Dec 31, 2024 | 245.12 Mn |
| Sep 30, 2024 | 273.04 Mn |
| Jun 30, 2024 | 292.54 Mn |
| Mar 31, 2024 | 188.18 Mn |
| Dec 31, 2023 | 191.22 Mn |
| Sep 30, 2023 | 142.38 Mn |
| Jun 30, 2023 | 153.52 Mn |
| Mar 31, 2023 | 164.87 Mn |
| Dec 31, 2022 | 175.70 Mn |
| Sep 30, 2022 | 65.29 Mn |
| Jun 30, 2022 | 72.35 Mn |
| Mar 31, 2022 | 79.93 Mn |
| Dec 31, 2021 | 85.91 Mn |
| Sep 30, 2021 | 91.84 Mn |
| Jun 30, 2021 | 42.81 Mn |
Celcuity Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=CELC&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "CELC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=CELC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();